Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Lymphoma, Large B-Cell, Diffuse, Date of authorisation: 22/09/2023, Status: Authorised
TO: